These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 16922467

  • 1. Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results.
    Küçük NO, Külak HA, Aras G.
    Ann Nucl Med; 2006 Jul; 20(6):393-7. PubMed ID: 16922467
    [Abstract] [Full Text] [Related]

  • 2. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D, Mazzarotto R, Casara D.
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [Abstract] [Full Text] [Related]

  • 3. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
    Küçük ON, Gültekin SS, Aras G, Ibiş E.
    Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246
    [Abstract] [Full Text] [Related]

  • 4. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S, Hadjieva T, Doldurova M, Stefanova S, Dudov A.
    J BUON; 2006 Mar; 11(4):511-8. PubMed ID: 17309186
    [Abstract] [Full Text] [Related]

  • 5. Tc-99m MIBI SPECT in detecting metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Hsu CH, Liu FY, Yen RF, Kao CH.
    Endocr Res; 2003 Feb; 29(1):9-15. PubMed ID: 12665314
    [Abstract] [Full Text] [Related]

  • 6. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M, Kasagi K, Misaki T, Matsumoto K, Iida Y, Ishimori T, Nakamoto Y, Higashi T, Saga T, Konishi J.
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
    Wu HS, Huang WS, Liu YC, Yen RF, Shen YY, Kao CH.
    Anticancer Res; 2003 Apr; 23(5b):4235-8. PubMed ID: 14666632
    [Abstract] [Full Text] [Related]

  • 9. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC, Sundram FX, Sin AE.
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic value of technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) scintigraphy in detecting thyroid cancer metastases: a critical evaluation.
    Alam MS, Kasagi K, Misaki T, Miyamoto S, Iwata M, Iida Y, Konishi J.
    Thyroid; 1998 Dec; 8(12):1091-100. PubMed ID: 9920363
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma.
    Sriprapaporn J, Toopmongkol C, Satayaban B, Chantamoon N.
    Ann Acad Med Singap; 2002 Mar; 31(2):195-8. PubMed ID: 11957557
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
    Biscontini G, Possa M, Sara R, Milella M, Rossetti C.
    Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P, Gallowitsch HJ.
    Acta Med Austriaca; 1996 Dec; 23(1-2):69-75. PubMed ID: 8767519
    [Abstract] [Full Text] [Related]

  • 17. The Value of 99mTc-MIBI SPECT/CT in the Postoperative Assessment of Patients with Differentiated Thyroid Carcinoma.
    Okudan B, Seven B, Gülaldı NCM, Çapraz M, Açıkgöz Y.
    Curr Med Imaging; 2022 Dec; 18(4):404-408. PubMed ID: 34749623
    [Abstract] [Full Text] [Related]

  • 18. Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography.
    Casara D, Rubello D, Saladini G, Mazzarotto R, Sotti G, Tomasella G, Pelizzo MR.
    Tumori; 1999 Dec; 85(2):122-7. PubMed ID: 10363078
    [Abstract] [Full Text] [Related]

  • 19. Clinical Value of 99mTc-3PRGD2 SPECT/CT in Differentiated Thyroid Carcinoma with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Level.
    Gao R, Zhang GJ, Wang YB, Liu Y, Wang F, Jia X, Liang YQ, Yang AM.
    Sci Rep; 2018 Jan 11; 8(1):473. PubMed ID: 29323252
    [Abstract] [Full Text] [Related]

  • 20. Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Almeida-Filho P, Ravizzini GC, Almeida C, Borges-Neto S.
    Clin Nucl Med; 2000 Jun 11; 25(6):443-6. PubMed ID: 10836693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.